Dual antiplatelet therapy for reduction in mortality in patients with acute and chronic coronary syndromes
Dual antiplatelet therapy (DAPT) is a foundation of successful coronary artery disease management. DAPT is recommended according to ESC guidelines for 6 months following elective percutaneous coronary intervention and for 12 months following the acute coronary syndrome (ACS). ACS are the most cost-c...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2021-12-01
|
| Series: | Advances in Interventional Cardiology |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Dual-antiplatelet-therapy-for-reduction-in-mortality-in-patients-with-acute-and-chronic-coronary-syndromes,35,45950,1,1.html |